AbbVie Inc.ABBVNYSE
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank92
Year-over-Year Change
Year-over-year net income growth rate
Latest
876.34%
↑ 52% vs avg
Percentile
P92
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
577.92%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 876.34% |
| Q3 2025 | -80.17% |
| Q2 2025 | -27.06% |
| Q1 2025 | 5945.45% |
| Q4 2024 | -101.41% |
| Q3 2024 | 13.94% |
| Q2 2024 | 0.07% |
| Q1 2024 | 66.55% |
| Q4 2023 | -53.77% |
| Q3 2023 | -12.15% |
| Q2 2023 | 746.86% |
| Q1 2023 | -90.34% |
| Q4 2022 | -37.38% |
| Q3 2022 | 327.38% |
| Q2 2022 | -79.42% |
| Q1 2022 | 11.03% |
| Q4 2021 | 27.21% |
| Q3 2021 | 315.01% |
| Q2 2021 | -78.44% |
| Q1 2021 | 9769.44% |
| Q4 2020 | -98.44% |
| Q3 2020 | 412.74% |
| Q2 2020 | -124.52% |
| Q1 2020 | 7.46% |
| Q4 2019 | 48.67% |
| Q3 2019 | 154.25% |
| Q2 2019 | -69.83% |
| Q1 2019 | 234.50% |
| Q4 2018 | -166.47% |
| Q3 2018 | 38.53% |
| Q2 2018 | -28.75% |
| Q1 2018 | 5251.92% |
| Q4 2017 | -96.81% |
| Q3 2017 | -14.83% |
| Q2 2017 | 11.92% |
| Q1 2017 | 23.01% |
| Q4 2016 | -12.95% |
| Q3 2016 | -0.75% |
| Q2 2016 | 18.91% |
| Q1 2016 | -10.74% |